News

Discover the science behind cosmeceutical advancements and the importance of staying informed for enhanced patient care with Zoe Diana Draelos, MD.

The phase 3 studies, BE HEARD I and BE HEARD II, showed significant improvements in skin pain over the 48-week period.

In addition to recapping key highlights from his session, Friedman discusses what is new or upcoming in dermatology that most excites him.

Catch up on coverage from the second day of the 2024 American Academy of Dermatology Annual Meeting.

The international observational study aims to understand how moderate to severe AD affects children under 12 years of age, particularly in terms of height, weight, and BMI.

Keep up with the latest headlines in dermatology from the past week, including benzene findings reported by independent laboratory Valisure, Galderma's plans for a $2.3 billion IPO on the Swiss stock exchange, and more.

Alexandra Kimball, MD, FAAD, reviews late-breaking data at AAD on lutikizumab for hidradenitis suppurativa.

Dermatologists are able to connect pediatric patients to psychology clinicians for multidisciplinary care under one roof.

In an AAD late-breaking research session, Joel Gelfand, MD, MSCE, FAAD, presented in-depth results of the LITE Study.

Iltefat Hamzavi, MD, reviews late-breaking data at AAD on upadacitinib as monotherapy.

The American Acne and Rosacea Society welcomed Del Rosso as its new president and he shared key takeaways from his AAD sessions.

Christopher Bunick, MD, PhD, provides tips for the general dermatologist to treat ichthyosis and shares data on TMB-001 in development for ichthyosis.

Lio delves into his American Academy of Dermatology Annual Meeting session, "Dietary Triggers and Modifications of Common Dermatologic Conditions: An Evidence Based Approach."

Catch up on coverage from the first day of the 2024 American Academy of Dermatology Annual Meeting.

Neal Bhatia, MD, shares his insights on successfully navigating AAD and his session highlights on office politics.

Chovatiya acknowledged the common sentiment among residents who, despite dedicating significant time to studying and working during residency, may feel unprepared.

"We cannot do health equity outside of an institution unless we figure out how to get our own house in order," the AMA leader said.

The 20th Annual Skin of Color Society Scientific Symposium featured diverse research including studies on traction alopecia among individuals with religious head coverings, challenges in color-matching universal tinted sunscreens, dermatologic disparities in American Indian/Alaskan Native populations, and more.

In celebration of Women's History Month and today, which is International Women's Day, dermatologist Nicole Negbenebor, MD, discusses her journey in the dermatology space and provides advice for young women and girls aspiring to enter the medical field.

New data was presented at the American Academy of Dermatology Annual Meeting in San Diego, California.

Maggi Ahmed, MD, PhD, demonstrated superior pigmentation outcomes and reduced CD8+ T cell numbers in her recent research results.

Today is International Women's Day. Dermatology Times spoke with 5 women clinicians in the field to discuss the influences and advice that brought them to where they are today.

Click here to answer our poll and let us know what disease states, topics, and research you most want to see news about throughout the conference.

Read more on what you can expect at this year’s AAD meeting and how to navigate all the opportunities.

Following the announcement of Valisure's findings related to benzene and benzoyl peroxide acne products, Dermatology Times spoke with David Light, co-founder and president of the laboratory behind the report, to discuss the findings, the role of stability testing requirements, and quelling fear-filled online discourse.

We've rounded up commentary from trusted dermatology experts who expressed enthusiasm and excitement for the biggest dermatology meeting of the year.

The organization celebrates 2 decades of leading awareness, research, education, membership, and advocacy for clinicians and patients with skin of color.

Among the many sessions to be held at the American Academy of Dermatology Annual Meeting in San Diego, California, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

Alphyn’s first-in-class therapeutic is designed to treat the immune system component, and more specifically the bacterial component, of AD.

In our March publication, Winter Editor in Chief Christopher Bunick, MD, PhD, delved into the growing concern of benzene in personal care products. This commentary becomes all the more important in light of the recent findings of high levels of benzene in acne products.